baber/WOPTO huggingface dataset:
Patent JP-2002501469-A (JP)
Title: 気相合成によりダイヤモンド層を得る方法
IPC: C23C16/27
Filed: 1997-04-16
Abstract: (57)【要約】
本明細書に開示した気相合成によりダイヤモンド皮膜を得るための方法は、カソードとアノードのギャップを通って流れる水素中で直流グロー放電を発生させることを含む。基材を７００〜約９００℃の温度に加熱する。誘電性基材および導電性基材のいずれにも、電流密度０．３〜２Ａ／ｃｍ 2 でダイヤモンド皮膜を析出させる。析出は、ガス流中３〜１０％の炭素含有ガス濃度の水素と炭素含有ガスの混合物中で行われる。次いで水素流中で放電して不必要な黒鉛を５〜１０分間除去する。炭素含有ガスは、３〜８％濃度のメタンよりなるものであってもよく、基材をグリッドアノードから０．１〜５ｍｍの距離で、放電ギャップ外において接地または断路した基材ホルダー上に配置できる。アノードは、直径０．１〜１ｍｍ、ピッチ１〜３ｍｍのモリブデンワイヤのアレイ状に作成される。導電性基材上でのダイヤモンド層の析出プロセス中は、基材をアノード上に配置できる。シリコン基材上でのダイヤモンド層の析出プロセスの場合、水素流中、電流０．３〜２Ａ／ｃｍ 2 で１０〜２０分間、基材から天然の酸化ケイ素をまず除去する。７〜１２％のメタンをガス流に１０〜２０分間導入することにより、基材に炭化ケイ素層を形成する。この方法で得たダイヤモンド層はナノ結晶質構造をもち、これにより放出閾値が最高３〜４Ｖ／μｍ、電流密度が１００ｍＡ／ｃｍ 2 を超える層が得られる。これらの特性により、このダイヤモンド層をフラットパネルディスプレーの製造、電子顕微鏡、マイクロ波エレクトロニクス、その他の多数の用途に使用できる。
Patent JP-2001520669-A (JP)
Title: 小型哺乳動物の寝床のノミを根絶する方法および手段
IPC: A01N43/56
Filed: 1998-03-25
Abstract: (57)【要約】
小型哺乳動物、特にネコおよびイヌの居場所または寝床のノミ、ダニ、シラミを根絶するための組成物製造での式Ｉまたは式ＩＩの化合物の使用。式Ｉまたは化学式ＩＩの化合物の殺虫有効量の点状塗布用製剤を毎月定期的に居場所または寝床の動物に塗布する。
Patent JP-2002500594-A (JP)
Title: 耐磨耗性及び耐腐食性改善のためのアーク溶接された端部処理を有するトラックブッシュ及びその製造プロセス
IPC: B62D55/088
Filed: 1999-03-10
Abstract: (57)【要約】
履帯型機械の無端状トラック用トラックブッシュ（１０）は第１端（２０）と、第２端（３０）と、縦方向軸線を有する円筒チューブ形状を含んでいる。トラックブッシュ（１０）は更に、第１端（２０）に隣接した第１端軸受表面（２２）と、第２端（３０）に隣接した第２端軸受表面（３２）を含んでいる。少なくとも第１端軸受表面（２２）及び第２端軸受け表面（３２）の内の一つに円周溝（１２，１３）が形成されている。円周溝（１２，１３）は縦方向軸線に沿った深さを有している。耐磨耗性及び耐腐食性物質（１４，１５）がブッシュ（１０）の円周溝（１２，１３）中の溶接ジョイントにアーク溶接されている。
Patent JP-2002503380-A (JP)
Title: リストストラップ試験モード回路
IPC: A61B5/05
Filed: 1998-05-08
Abstract: (57)【要約】
静電荷放電拡散システムであって、使用者が着用するリストストラップに取付けたタグに組み込んだ電子回路。前記電子回路は、発振器と、信号送信器と、放電抵抗器（２２）と、放電抵抗器（２２）の精度を監視するための放電抵抗器チェック回路と、リストストラップとその着用者との電気的な接続を監視するための皮膚抵抗チェック回路と、リストストラップと接地間の電気的な接続を監視するための接地故障検出回路と、さらに、発振器の周波数をチェックし、接地故障検出回路と皮膚抵抗チェック回路の機能をチェックし、また放電抵抗器（２２）の上限値と下限値をチェックし、また信号送信器から送られる信号のスペクトルを監視するためのタグ機能試験回路とを備える。
Patent MD-20020244-A (MD)
Title: Hot-water boiler
Inventor: SOCOLOV VALERIU
IPC: F24H1/00
Filed: 2002-10-02
Abstract: The invention relates to the heat engineering and may be used in the water heating systems as well as for water heating for everyday necessities. The hot-water boiler contains a body, a combustion chamber with burner, a water jacket, water inlet and outlet pipes, flue gas escape channels, horizontal convective heating surfaces, forming gas ducts in the form of labyrinth, and tubular heat exchangers coupled with the water jacket. The boiler supplementary contains water heating unit for everyday necessities, a computer data processing and control unit, a monitor unit, a hot water distribution unit, a protection unit, a remote control and a power unit. Claims: 2Fig.: 1
Patent NZ-196250-A (NZ)
Title: Imidazole derivatives and pharmaceutical compositions
Inventor: KARJALAINEN A
IPC: C07D233/64
Filed: 1981-02-12
Abstract: The invention provides compounds of the formula:wherein each of R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub>, which can be the same or different is hydrogen, chloro, bromo, fluoro, methyl, ethyl, methoxv, amino, hydroxy or nitro; R<sub>4</sub> is hydrogen or alkyl of 1 to 7 carbon atoms; X is(R<sub>5</sub> is hydrogen or hydroxy) and n is 1-4; and their non-toxic pharmaceutically acceptable acid addition salts. These compounds exhibitvaluable pharmacological activity and are useful in the treatment of mammals, especially as anti- hypertensive agents. Furthermore, some of the compounds have proved to possess diuretic, ß-blocking activity and/or antithrombotic activity. The compounds may be made by a variety of methods and may be incorporated in pharmaceutical compositions also comprising a compatible pharmaceutically acceptable carrier.
Patent NZ-208075-A (NZ)
Title: Amide derivatives and sweetening compositions
Inventor: VERLANDER M S
IPC: C07C49/395
Filed: 1984-05-07
Abstract: Compounds of the formula: <CHEM> wherein n is 0 or 1, R is lower alkyl (substituted or unsubstituted), R min  is H or lower alkyl, and R sec  is a branched alkyl, alkyl-cycloalkyl, cycloalkyl, polycycloalkyl (poly = 2 or more, fused or non-fused), phenyl or alkyl-substituted phenyl, and physiologically acceptable cationic and acid addition salts thereof, which compounds are potent sweeteners. These derivatives of gem-diaminoalkanes are many times sweeter than sugar and are free from undesirable flavor qualities. Furthermore, they possess an unanticipated high degree of solubility compared with known synthetic sweeteners. In addition, the compounds possess high stability so that they can be used in all types of beverages and in conventional food processing. Sweetening compositions and sweetened edible compositions of these compounds are also provided.
Patent NZ-216832-A (NZ)
Title: Bovine growth hormone implant
Inventor: JANSKI A M
IPC: A61K9/22
Filed: 1986-07-14
Abstract: The present invention provides improved controlled release implants for subcutaneous administration to an animal of a growth promoting amount of a recombinant protein having growth hormone activity, characterised in that said protein is present in a form having a salt content of less than 5% by weight based on the weight of said protein.
Patent NZ-218235-A (NZ)
Title: Effervescent ibuprofen composition
Inventor: KHAN K A
IPC: A61K47/26
Filed: 1986-11-10
Abstract: Novel pharmaceutical powder and tablet compositions comprise ibuprofen or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable effervescent couple that produces carbon dioxide in the presence of water, a pharmaceutically acceptable surfactant and a pharmaceutically acceptable water-insoluble hydrophilic polymer. Preferred hydrophilic polymers are microcrystalline cellulose and croscarmellose sodium.Especially preferred are such compositions which have a saccharide dispersed therein. The incorporation of the saccharide, for example sucrose, lactose, dextrose or sorbitol, enhances the stability of the compositions.
Patent NZ-218596-A (NZ)
Title: System for the controlled release of active substances
Inventor: COLOMBO PAULO
IPC: A61K9/22
Filed: 1986-12-11
Abstract: A system for the controlled-rate release of active substances, consisting of:a) a deposit-core comprising the active substance and having defined geometric form;b) a support-platform applied to said deposit-core.Said deposit-core contains, mixed with the active substance, a polymeric material having a high degree of swelling on contact with water or aqueous liquids, a gellable polymeric material, said polymeric materials being replaceable by a single polymeric material having both swelling and gelling properties, and other adjuvants able to provide the mixture with suitable characteristics for its compression and for its intake of water.Said support-platform consists of a polymeric material insoluble in aqueous liquids and partially coating said deposit-core.The intensity and duration of the swelling force of said polymeric material with a high degree of swelling constitutes the primary factor in controlling the release of the active substance.
Patent NZ-219126-A (NZ)
Title: Automatic fine tuning of tv receiver derived during blanking interval
Inventor: TESTIN WILLIAM JOHN
IPC: H04N5/50
Filed: 1987-01-30
Abstract: In a tuning control system for a television receiver, an analog AFT signal is sampled during blanking intervals when the amplitude of the video carrier is relative constant and therefore cannot affect the amplitude of the AFT signal significantly. This reduces the AFT filtering requirements.
Patent NZ-231228-A (NZ)
Title: Toilet bar based on soap with a hydrated cationic guar gum component
Inventor: KNOCHEL JOHN ROBERT
IPC: C11D3/22
Filed: 1989-11-01
Abstract: Toilet bar compositions containing alkali metal soap and cationic guar gum provided by a fast hydrating cationic guar gum. The bars exhibit improved bar feel. The formulations of the bars have improved processability. The toilet bars comprise alkali metal soap and from about 0.2% to about 5% by weight of the fast hydrating cationic guar gum.
Patent NZ-232601-A (NZ)
Title: Pyrimidine derivatives and use
Inventor: GEISEN KARL
IPC: A61K31/505
Filed: 1990-02-20
Abstract: Pyrimidine derivatives of the formula I   <IMAGE> I  in which R1, R2, R3, R4 and R5 have the indicated meanings, the salts thereof, and a process for the preparation thereof are described. Because of their sorbitol-accumulating activity, they are suitable as a tool in a pharmacological screening model for aldose reductase inhibitors.
Patent NZ-234125-A (NZ)
Title: Heated-treated milk protein beverage includes coffee or tea, a buffer, kappa carrageenan and a chelating agent
Inventor: KWON SOON-YOUNG
IPC: A23F3/16
Filed: 1990-06-19
Abstract: A ready-to-serve heat treated beverage comprising a beverage vehicle containing milk protein, a beverage base containing coffee or tea, a buffering agent, kappa carrageenan in an amount up to 0.010% and a chelating agent for cations in an amount up to 0.25% containing at least 0.005% of sodium alginate and/or propylene glycol alginate, the said amounts being by weight based on the total weight of the beverage.
Patent NZ-236315-A (NZ)
Title: Nitrogen-containing spirocycles, preparation and pharmaceutical compositions thereof
Inventor: BALDWIN JOHN J
IPC: C07D498/10
Filed: 1990-12-03
Abstract: Spirocycles of general structural formula <CHEM> are Class III antiarrhythmic agents.
Patent NZ-239711-A (NZ)
Title: Mometasone furoate monohydrate and pharmaceutical compositons
Inventor: PUI-HO YUEN
IPC: A61K9/08
Filed: 1991-09-09
Abstract: The invention relates to the novel compound mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing said compound.
Patent NZ-277579-A (NZ)
Title: Diaper; details regarding positioning of absorbent body unit
Inventor: WIDLUND URBAN
IPC: A61F5/44
Filed: 1994-12-08
Abstract: PCT No. PCT/SE94/01178 Sec. 371 Date Jun. 5, 1996 Sec. 102(e) Date Jun. 5, 1996 PCT Filed Dec. 8, 1994 PCT Pub. No. WO95/16418 PCT Pub. Date Jun. 22, 1995A diaper having a front part (12), a back part (14) and an intermediate crotch part (13) which includes an absorbent body unit (1) which is joined to a fluid-impermeable bottom sheet (7) and to a fluid-permeable top sheet (9) which lies proximal to the wearer's body in use and which includes an opening (15) situated in the back part and crotch part of the diaper and stretch-mounted elastic devices (20, 21), and which is not attached to the absorbent body unit at least within the region of the opening (15). The absorbent body unit (1) includes a main body (2) which is provided with a leg recess on respective sides thereof, and two side-bodies (3, 4) which are placed laterally outside the main body on respective sides thereof and in respective leg recesses. The absorbent body unit (1) is enclosed between the bottom sheet (7) and an inner casing sheet (8) made of fluid-permeable material, the sheets being mutually joined at parts which lie outside the absorbent body unit and carry stretch-mounted elastic elements (10, 11) along their respective side edges within at least the central part of the diaper. Each side-body (3, 4) has an arcuate edge on that side (22) thereof which lies proximal to a respective leg recess in the main body (2). The side-bodies are spaced from the main body (2); and the inner casing sheet (8) is joined to the bottom sheet (7) in those gaps that are formed in the leg recesses between the main body and the side-bodies.
Patent NZ-280659-A (NZ)
Title: Flavouring agent; moromi or a moromi fraction mixed with yeast lysate to convert the amp of the lysate to imp
Inventor: BENGTSSON BENGT
IPC: A23L27/10
Filed: 1995-12-13
Abstract: Prodn. of a flavouring agent comprises mixing a yeast lysate with moromi or a moromi fraction and allowing the mixt. to react at 30-70 degrees C to convert adenosine monophosphate (AMP) to inosine monophosphate (IMP).
Patent NZ-280805-A (NZ)
Title: Benzofuran derivatives, preparation, and pharmaceutical compositions thereof
Inventor: LESIEUR DANIEL
IPC: C07C233/02
Filed: 1996-01-10
Abstract: Hetero-cycloalkyl derivs. of formula (I) and their enantiomers and diastereoisomers are new. R1 = alkyl opt. substd. by Q; or cycloalkyl or cycloalkylalkyl, both opt. substd. by Q'; A together with the benzene gp. = tetrahydronaphthalene, dihydronaphthalene, naphthalene, benzothiophene, 2,3-dihydrobenzothiophene; or indoline or indole both opt. N-substd. by Ra, CORa or CO2Ra; Ra = alkyl, Ph or phenylalkyl; R2 = H or alkyl; R3 = C(=X)R4 or C(=X')NHR5; X, X' = S or O; R4 = H, alkenyl, alkynyl, alkyl opt. substd. by Q, or cycloalkyl or cycloalkylalkyl both opt. substd. by Q'; R5 = H, alkyl opt. substd. by Q, or cycloalkyl or cycloalkylalkyl both opt. substd. by Q'; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; Q = halo, OH, alkyl or alkoxy; Q' = halo, alkyl or oxo.
Patent NZ-298355-A (NZ)
Title: Method of reducing allograft transplant rejection by contacting donor tissue with photosensitizing agent followed by light
Inventor: OBOCHI MODESTUS ONUORA KAY
IPC: A61K41/00
Filed: 1996-01-12
Abstract: A method for diminishing the immunogenicity of donor tissue containing antigen presenting cells (APC's) is claimed comprising: a) contacting the donor tissue with a photosensitizing agent in a therapeutically effective amount of less than 6mg/ml to obtain a modified donor tissue; b) exposing the modified donor tissue to light having a wavelength absorbed by the photosensitizing agent for a time sufficient to attenuate the APC's in the donor tissue wherein the exposed donor tissue reduces the rejection of allografts comprising the tissue.
Patent NZ-324588-A (NZ)
Title: Purified xylanase, derived from acidothermus cellulolyticus, having a pH optimum of 3.6 to 4.2 and a Mr of 50-55kD
Inventor: CLARKSON KATHLEEN A
IPC: A23K1/18
Filed: 1996-12-03
Abstract: A purified xylanase having a pH optimum of about  3.6 to 4.2 and a molecular weight of about 50-55kD as determined by gel filtration derived from Acidothermus cellulolyticus where the xylanase has a temperature optimum of about 70-80oC. Also claimed is a feed additive comprising the above xylanase, and a method for bleaching pulp with a sulphite or kraft pulp with xylanase, and a method for increasing the digestability of a cereal-based animal feed.
Patent NZ-502874-A (NZ)
Title: Antihyperlipidemic statin-lp(a) inhibitor combinations
Inventor: BISGAIER CHARLES LARRY
IPC: A61K31/365
Filed: 1998-11-04
Abstract: A pharmaceutical composition for oral administration comprising: a) an amount of an Lp(a) inhibitor b) an amount of a statin c) a pharmaceutically acceptable carrier or diluent. Also disclosed is a kit for achieving a therapeutic benefit in a mammal comprising: a) an amount of an Lp(a) inhibitor in a first unit dosage form b) an amount of a statin in a second unit dosage form c) container means for containing said first and second dosage forms.
Patent NZ-504173-A (NZ)
Title: Medication dispensing folder in the form of two side hinged panels being fastenable to each other with blister pack and sheet sandwiched between panels, and sheet for this purpose
Inventor: STEVENS GERARD
IPC: A61J1/03
Filed: 2000-04-28
Abstract: Blister card 5 is located between folder 1 panels 3,4 with sheet 13 folded at line 14 and located over blister cards 5 but inside panels 3,4.  This enables a user to select medication for particular days/times with sheet 13 being re-usable.
Patent NZ-504366-A (NZ)
Title: Method and apparatus for applying 5-aminolevulinic acid (5-amino-4-oxo-pentanoic acid)
Inventor: GOLUB ALLYN
IPC: A61J1/00
Filed: 1998-10-30
Abstract: A method of storing, mixing and applying 5-aminolevulinic acid which inhibits exposure of the 5-aminolevulinic acid to air and moisture until just prior to application, said method comprising: hermetically sealing essentially anhydrous 5-aminolevulinic acid within a first essentially frangible compartment; disposing said first compartment within a deformable container, said container having an applicator; deforming said container to crush said first compartment and mix said essentially anhydrous 5-aminolevulinic acid with a liquid diluent in said container; and topically applying 5-aminolevulinic acid from said container through said applicator.
Patent NZ-508895-A (NZ)
Title: Heat exchanger tracking
Inventor: INNES RODNEY MITCHELL
IPC: F28D9/04
Filed: 1999-06-25
Abstract: A spiral heat exchanger having coils (2).  The track (3) between the coils providing a second fluid flow path.  Spacers (5) keep the coils apart.  Spacer baffles (8) allow the stacking of the coils within a container (9).
Patent NZ-512467-A (NZ)
Title: Cables with a recyclable coating
Inventor: SCELZA CRISTIANA
IPC: H01B3/44
Filed: 1999-12-21
Abstract: Cable, in particular for medium-voltage or high-voltage electrical power transmission or distribution, for telecommunications or for data transmission, comprising a conductor and at least one coating layer based on a non-crosslinked polymer material comprising a heterogeneous copolymer with an ethylene-based elastomeric phase copolymerised with an á-olefin and a propylene-based thermoplastic phase, in which the said elastomeric phase in the said heterogeneous copolymer is at least 45 % by weight relative to the total weight of the heterogeneous copolymer, and the said heterogeneous copolymer is essentially free of crystallinity deriving from polyethylene sequences. The graph shows a DSC curve of one type of heterogeneous copolymer as described (Copolymer 1)
Patent NZ-512657-A (NZ)
Title: Glucagon suppression
Inventor: YOUNG ANDREW
IPC: A61K38/22
Filed: 2000-01-14
Abstract: Methods for use of an exendin, an exendin agonist, or a modified exendin or exendin agonist having an exendin or exendin agonist linked to one or more polyethylene glycol polymers, for example, for lowering glucagon levels and/or suppressing glucagon secretion in a subject are provided. These methods are useful in treating hyperglucagonemia and other conditions that would be benefited by lowering plasma glucagon or suppressing glucagon secretion. With the proviso that the exendin, exendin analogue, modified exendin, or modified exendin analogue comprises an exendin or exendin analogue which is at least 31 amino acids long.
Patent NZ-513062-A (NZ)
Title: HER-2/neu fusion proteins
Inventor: CHEEVER MARTIN A
IPC: A61K35/76
Filed: 2000-01-28
Abstract: The present invention is generally directed to HER- 2/neu fusion proteins, nucleic acid molecules encoding HER- 2/neu fusion proteins, viral vectors expressing HER-2/neu fusion proteins, and pharmaceutical compositions (e.g.vaccines) comprising the HER-2/neu fusion proteins and/or nucleic acid molecules encoding the HER-2/neu fusion proteins. The present invention is also directed to methods of manufacturing medicaments for treating or preventing cancer by eliciting or enhancing an immune response to the HER-2/neu protein, including for uses in the treatment of malignancies associated with the HER-2/neu oncogene.
Patent NZ-513394-A (NZ)
Title: Method and kit for repairing a construction component
Inventor: HAGEL RICHARD C
IPC: E06B1/06
Filed: 2000-02-17
Abstract: A method and kit for repairing a construction component (10) that has a damaged portion (12, 14).  First, the damaged portion (12, 14) is removed from the construction component (10).  Next, a durable portion (32, 34) is provided that is preferably comprised of a cellulosic/polymer composite material which is moisture, decay, and insect resistant.  The durable portion (32, 34) preferably has about the same shape as the damaged portion (12, 14).  The durable portion (32, 34) is then connected to the construction component (10) to replace the damaged portion (12, 14).  The materials for repairing the construction component (10) may be provided as a single kit.
Patent NZ-513825-A (NZ)
Title: C 16 unsaturated FP-selective prostaglandins analogs
Inventor: DELONG MITCHELL ANTHONY
IPC: C07C405/00
Filed: 2000-02-29
Abstract: Compounds having the general structure: which are useful for the treatment of a variety of diseases and conditions, such as bone disorders.
Patent NZ-524848-A (NZ)
Title: Trace elements
Inventor: LAURIE ROBERT NAYLOR
IPC: A23K1/175
Filed: 2001-08-17
Abstract: A method of preparing a trace element solution, the method consisting essentially of the steps of: (A) preparing a single solution comprising more than one EDTA complex having at least one sodium counter-ion in a single continuous process by suspending either disodium EDTA in water or suspending EDTA acid in water with sodium hydroxide, and adding a metal compound selected from the group consisting of metal oxides, metal hydroxides and metal carbonates tot eh EDTA solution to form the EDTA complex, and (B) adding sodium selenite to the solution of EDTA complexes to form the trace element solution in which the molar ratio of selenium to the metals in the EDTA complexes is from 1:4.8 to 1:19. Also disclosed is a method of providing trace elements to animals, such as livestock, which comprises preparing a solution as above and providing the solution to the animals.
Patent NZ-527900-A (NZ)
Title: PRO361 polypeptides and nucleic acids with homology to mucin and chitinase
Inventor: BAKER KEVIN P
IPC: C12N5/08
Filed: 1998-12-01
Abstract: An isolated nucleic acid encodes a polypeptide having at least 80% identity to an amino acid sequence shown in Figure 37 (SEQ ID NO:91), and can comprise the nucleotide sequence shown in Figure 36 (SEQ ID NO:90) or the sequence of the DNA deposited under accession number ATCC 209621. The polypeptide is associated with cancer, plant pathogenesis and receptor functions. Non-human host cells, vectors, antibodies, chimeric molecules and processes for producing the polypeptide are described. (62) Divided out of 522634
Patent NZ-529762-A (NZ)
Title: Use of duckweed in high throughput screening
Inventor: STOMP ANNE-MARIE
IPC: C12Q1/6897
Filed: 2002-05-30
Abstract: A high-throughput method for identifying a nucleic acid molecule of interest, said method comprising the steps of: (a) transforming a duckweed plant culture, duckweed nodule culture, duckweed suspension culture, or duckweed protoplast cell culture with a test nucleotide sequence comprising a coding sequence for a polypeptide; (b) culturing the duckweed plant culture, duckweed nodule culture, duckweed suspension culture, or duckweed protoplast cell culture under conditions such that the polypeptide encoded by the test nucleotide sequence is expressed; and (c) determining whether the polypeptide encoded by the test nucleotide sequence modulates a biological response, wherein a test nucleotide sequence that encodes a polypeptide that modulates a biological response is identified as a nucleic acid molecule of interest; wherein steps (a) and (b) are performed in the same high density format plate or container.
Patent NZ-531000-A (NZ)
Title: Portable hydro electric generating apparatus
Inventor: KNIGHT WILLIAM DOWDEN
IPC: F03B7/00
Filed: 2004-02-09
Abstract: Generation of electricity by using a portable hydro-electric generating device is disclosed. The apparatus consists of a turbine 3 being driven by the circulation of water through a flow/return pipe 7. Battery powered pumps 2, 14 maintain water pressure in the pipe. A flywheel 10 and gears 11connect the turbine to a generator 12, while centrifugal machine 9 regulates the output.
Patent NZ-537340-A (NZ)
Title: Method and system for installing a water storage device
Inventor: WIGGINS STEVEN JOHN
Filed: 2004-12-21
Abstract: A method and system for installing a flexible liner in a tank for water storage. At least three substantially rigid extensions attached to and extending outwardly from the liner are received in corresponding apertures in the tank to ensure correct positioning.